Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether dry powder inhalation of Cyclosporine A
is beneficial in lung transplant patients with Bronchiolitis Obliterans Syndrome. For
patients suffering from this syndrome often no therapeutic options are available.
Furthermore, the side effects of the maintenance therapy leaves no room for dose increments.
The hypothesis for this trial is that when Cyclosporine A is administered locally (in the
lungs) chronic rejection can be treated more effectively without extra systemic side effects.